SummaryThe Delhi High Court has granted interim protection to JNTL Consumer Health, allowing the company to sell its existing ₹180 crore stock of ORSL despite FSSAI’s prohibition on using “ORS” in product names. Hyderabad paediatrician Dr. Sivaranjani Santosh, who has campaigned for years against misleading medical-sounding labels, has renewed her call for strict regulatory action, warning that such branding could endanger children’s health.